European Journal of Medicinal Chemistry p. 423 - 436 (1998)
Update date:2022-08-05
Topics: Synthesis Inhibitors Catalyst Purification Reaction Conditions Activity Biological assay HIV protease
Garrouste, Patrick
Pawlowski, Macek
Tonnaire, Thierry
Sicsic, Sames
Dumy, Pascal
De Rosny, Eve
Reboud-Ravaux, Michele
Fulcrand, Pierre
Martinez, Jean
We report here the synthesis and activity of HIV protease inhibitors. In the first stage hydrophobic compounds incorporating a 'carba' bond surrogate or a beta-homologated residue were synthesized. Secondly, we synthesized cyclic compounds in which we incorporated 2-quinoline carboxylic acid in the P3 position and the amino-hydroxyindane moiety in the P'3. The last part of this work was dedicated to a structure/activity study of a peptide substrate. These modifications allowed us to work up the synthesis of new pseudopeptide bonds: amino-amide and hydroxy-amide. Compounds with activity in the micromolar range were actually a starting point for the synthesis of new protease inhibitors.
View MoreContact:+86-0512-88957371
Address:shanghai
Contact:021-36356756
Address:Room601,Building No.14,280 Yangcheng Road,Shanghai
Dongguan Albiya Energy Science and Technology Co.,Ltd
Contact:+86-769-22181286
Address:Huanan Industial Park, Dongguan,China
Jiangxi Huashi Pharmaceutical Co., Ltd
Contact:+86-795-4509628
Address:Ningbo Ave., Fengtian Industrial Park, Fengxin Country, Jiangxi, China.
Hangzhou Ocean Chemical Co., Ltd.
website:http://www.hzoceanchem.com
Contact:+86-571-88025872, 28272092, 28272096
Address:Room 623 ,Building No 1 , COFCO Radius Commercial Center Xiwen Road, Xiacheng District, Hangzhou, Zhejiang Province, China
Doi:10.1016/j.ejmech.2018.11.060
(2019)Doi:10.1007/BF02232534
(1970)Doi:10.1021/jm030003x
(2003)Doi:10.1016/S0014-827X(01)01134-X
(2001)Doi:10.1107/S2053229617012761
(2017)Doi:10.1021/jo990055n
(1999)